Aripiprazole: all 299 studies that test it
Page 3 of 3. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk PrediabeticsCompletedNCT01411930Phase 4
- Aripiprazole and Resistant Postpartum DepressionCompletedNCT01386086Phase 3
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaCompletedNCT01164059Phase 4
- Effects of Aripiprazole and Haloperidol on Mesolimbic System FunctioningCompletedNCT01161277Phase 4
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)CompletedNCT01154829Not applicable
- Tolerance and Effect of Antipsychotics in Children and Adolescents With PsychosisCompletedNCT01119014Phase 4
- Aripiprazole and Prolactin StudyCompletedNCT01085383Phase 4
- ARIpiprazole in Anorexia NErvosaStatus unknownNCT01082848Phase 3
- Standard Comprehensive Intervention to Treat First-episode SchizophreniaStatus unknownNCT01057849Not applicable
- Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of SchizophreniaCompletedNCT01052389Phase 4
- Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and QuetiapineStatus unknownNCT01047215Phase 4
- Efficacy and Safety of Aripiprazole in First Episode PsychosisCompletedNCT01026584Phase 4
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic SyndromeCompletedNCT00956189Not applicable
- Metabolic Effects of Antipsychotic Substitution in ChildrenWithdrawnNCT00910780Phase 2/3
- Aripiprazole and Topiramate on Free-Choice Alcohol UseCompletedNCT00884884Phase 2/3
- Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major DepressionCompletedNCT00873795Not applicable
- Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar DisordersCompletedNCT00845988Phase 4
- Aripiprazole for Neuroleptic-Induced Tardive DyskinesiaStatus unknownNCT00837707Phase 4
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine DependenceStatus unknownNCT00737256Phase 2
- Aripiprazole for Methamphetamine Dependence: Double Blind Placebo TrialWithdrawnNCT00728312Phase 4
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNCT00712686Phase 3
- Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy SubjectsCompletedNCT00689559Phase 1
- A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsCompletedNCT00634348Phase 4
- Remediation of Schizophrenia Sensory Gating Deficit With AripiprazoleStatus unknownNCT00567099Not applicable
- Abilify in Bipolar Disorder for 24 Weeks Treatment EffectivenessCompletedNCT00545675Phase 4
- Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic AgentsCompletedNCT00545467Phase 4
- Abilify in Bipolar Disorder for 6 Weeks Treatment EffectivenessCompletedNCT00545142Phase 4
- Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and DyslipidemiaStatus unknownNCT00541554Phase 4
- Health Evaluation of Abilify Long-term TherapyCompletedNCT00520650Phase 4
- ABLE: Abilify in Bipolar Disorder for Long-term EffectivenessCompletedNCT00484471Phase 4
- The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole TrialStatus unknownNCT00468533Phase 4
- Aripiprazole in the Treatment of Post-Traumatic Stress Disorder SymptomsCompletedNCT00440713Phase 3
- Aripiprazole for the Treatment of Refractory AnxietyCompletedNCT00438386Phase 4
- Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of SchizophreniaStatus unknownNCT00395915Phase 4
- Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)CompletedNCT00374348Not applicable
- A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar DepressionCompletedNCT00363337Phase 4
- Aripiprazole and Effexor XR Drug Interaction StudyCompletedNCT00362271Phase 1
- Aripiprazole and Lexapro Drug Interaction StudyCompletedNCT00361790Phase 1
- Switch Study of Existing Atypical Antipsychotics to BifeprunoxCompletedNCT00347425Phase 3
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeWithdrawnNCT00338273Phase 3
- Effect on Cognitive Function of a Treatment With AripiprazoleCompletedNCT00329810Phase 4
- Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory SchizophreniaCompletedNCT00328367Phase 4
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.CompletedNCT00325689Phase 4
- Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I DisorderCompletedNCT00321516Phase 1
- Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHDCompletedNCT00305370Phase 4
- Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)CompletedNCT00304655Phase 4
- SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
- A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic PatientsCompletedNCT00300846Phase 4
- A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric PracticesCompletedNCT00292409Phase 3
- Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaCompletedNCT00283179Phase 3
- Aripiprazole in the Treatment of Tourette's SyndromeTerminatedNCT00282139Not applicable
- Aripiprazole Augmentation Therapy in Treatment-resistant DepressionWithdrawnNCT00276978Phase 3
- Aripiprazole to Reduce Cocaine RelapseCompletedNCT00276874Phase 1
- Study of Aripiprazole in Patients With Bipolar I DisorderCompletedNCT00257972Phase 3
- Side Effects of Newer Antipsychotics in Older AdultsCompletedNCT00245206Phase 4
- A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesCompletedNCT00237939Phase 3
- Schizophrenia Trial of AripiprazoleCompletedNCT00237913Phase 3
- Aripiprazole Treatment of Prodromal PatientsCompletedNCT00237874Phase 2/3
- A Switch Study of BMS-337039 in Schizophrenic Out-patientsCompletedNCT00232687Phase 4
- Aripiprazole in the Treatment of Bipolar DepressionCompletedNCT00226317Not applicable
- The Effects of Aripiprazole on Patients With Metabolic SyndromeCompletedNCT00224822Phase 4
- Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational SkillsCompletedNCT00223418Not applicable
- The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With SchizophreniaCompletedNCT00222833Phase 4
- Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)CompletedNCT00221962Phase 4
- An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar DisorderCompletedNCT00221416Phase 3
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)TerminatedNCT00211380Not applicable
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)TerminatedNCT00211302Not applicable
- Aripiprazole in Children With Autism: A Pilot StudyCompletedNCT00208533Phase 2
- Abilify Therapy for Reducing Comorbid Substance AbuseCompletedNCT00208169Phase 4
- Aripiprazole Treatment of Bipolar DepressionCompletedNCT00198198Phase 4
- A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.CompletedNCT00198055Phase 2
- Aripiprazole in Late Life Bipolar DisorderCompletedNCT00194038Phase 4
- Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar DisorderCompletedNCT00181779Phase 4
- Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietyCompletedNCT00177008Phase 4
- Aripiprazole Treatment of the ProdromeTerminatedNCT00169949Not applicable
- Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot StudyCompletedNCT00167817Phase 4
- Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00116259Not applicable
- Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00103571Phase 4
- Aripiprazole Oral Acceptability TrialCompletedNCT00101569Phase 3
- Study of Aripiprazole in Patients With Acute Bipolar ManiaCompletedNCT00097266Phase 3
- A Study of Adjunctive Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00095823Phase 3
- Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseCompletedNCT00095810Phase 4
- A Study of Adjunctive Aripiprazole in Participants With Major Depressive DisorderCompletedNCT00095758Phase 3
- Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With DementiaCompletedNCT00095719Phase 3
- Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderCompletedNCT00095524Phase 3
- Aripiprazole in Patients With Acute ManiaCompletedNCT00095511Phase 3
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeCompletedNCT00094432Phase 3
- Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Status unknownNCT00089440Phase 1
- Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaCompletedNCT00088049Phase 4
- Study of Aripiprazole in Subjects With AlcoholismCompletedNCT00082199Phase 4
- Study of Three Doses of Aripiprazole in Patients With Acute SchizophreniaCompletedNCT00080327Phase 4
- Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression EpisodeCompletedNCT00080314Phase 3
- Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar DisorderCompletedNCT00046384Phase 3
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00041678Phase 3
- Broad Effectiveness: Study With AripiprazoleCompletedNCT00036361Phase 3
- Study of Aripiprazole in Patients With a History of Bipolar DisorderCompletedNCT00036348Phase 3
- Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic DisordersCompletedNCT00036127Phase 2/3
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeCompletedNCT00036114Phase 3
- Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar DisorderCompletedNCT00036101Phase 3